Aspen Pharmacare (OTCPK:APNHY) is likely to be a very frustrating stock to many SA readers. While this company may be one of the best publicly-traded plays on the growth of the healthcare markets in Africa, Latin America, and Asia, the stock already sports a very steep multiple. What's more, its ADR shares are incredibly illiquid in the U.S., and only the Johannesburg-traded shares (APNJ.J) offer much liquidity. But for investors who can be patient, an opportunity to acquire shares in this company could be one of those rare once-in-a-decade opportunities.
South Africa Today, Australia Tomorrow, And Then The World
Aspen Pharmacare is one of the largest emerging market/developing world drug companies. Combining branded drugs, generics, and OTC, Aspen...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|